🇺🇸 FDA
Patent

US 11788141

MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells

granted A61KA61K35/17

Quick answer

US patent 11788141 (MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells) held by Precision for Medicine GmbH expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision for Medicine GmbH
Grant date
Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K35/17